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Replication forks frequently stall at regions of the
genome that are difficult to replicate or contain le-
sions that cause replication blockage. An important
mechanism for the restart of a stalled fork involves
endonucleolytic cleavage that can lead to fork
restoration and replication progression. Here, we
show that the structure-selective endonuclease
MUS81-EME2 is responsible for fork cleavage and
restart in human cells. The MUS81-EME2 protein,
whose actions are restricted to S phase, is also
responsible for telomere maintenance in telome-
rase-negative ALT (Alternative Lengthening of Telo-
meres) cells. In contrast, the G2/M functions of
MUS81, such as the cleavage of recombination inter-
mediates and fragile site expression, are promoted
by MUS81-EME1. These results define distinct and
temporal roles for MUS81-EME1 and MUS81-EME2
in the maintenance of genome stability.INTRODUCTION
The stability of our genome is dependent upon the efficient and
faithful replication of DNA. However, replication forks frequently
encounter obstacles to their passage, including DNA base
lesions, DNA interstrand crosslinks, difficult-to-replicate
sequences, transcription bubbles, or tightly bound proteins
(Branzei and Foiani, 2010). It is therefore imperative that replica-
tion forks that stall at these structures become reestablished to
ensure the transmission of equal copies of the genome to
daughter cells. One mechanism for the restart of a stalled repli-
cation fork involves nucleolytic cleavage mediated by the
MUS81 endonuclease (Hanada et al., 2007; Regairaz et al.,
2011). By acting upon the stalled fork, MUS81 generates a
DNA double-strand break (DSB) that can be repaired by homol-
ogous recombination, leading to the restoration of an active fork.
Such break-induced replication processes play critical roles in
maintaining genome stability in organisms ranging from bacteria
to yeasts and humans (Cox et al., 2000; Llorente et al., 2008).
MUS81 is a member of the XPF/MUS81 family of structure-
selective endonucleases (Ciccia et al., 2008). All enzymes
belonging to the family form heterodimeric complexes
composed of a catalytic and a noncatalytic subunit, and include
XPF-ERCC1, FANCM-FAAP24, MUS81-EME1, and MUS81-1048 Cell Reports 7, 1048–1055, May 22, 2014 ª2014 The AuthorsEME2 (catalytic subunits are indicated first). Although MUS81
has two partners in human cells, EME1 and EME2 (Ciccia
et al., 2003, 2007; Ogru¨nc¸ and Sancar, 2003), the S. cerevisiae
ortholog of MUS81 associates with a single partner, known as
Mms4, to form the Mus81-Mms4 endonuclease (Interthal and
Heyer, 2000; Kaliraman et al., 2001; Mullen et al., 2001).
Mus81-Mms4 plays an important role in the resolution of homol-
ogous recombination intermediates in both mitotic and meiotic
cells (Boddy et al., 2001; Matos et al., 2011; Szakal and Branzei,
2013). The Mms4 subunit is the target of cell-cycle regulation, as
Cdk/Cdc5-mediated phosphorylation events activate Mus81-
Mms4 at the G2/M transition in order to ensure that joint mole-
cule resolution occurs prior to chromosome segregation
(Gallo-Ferna´ndez et al., 2012; Matos et al., 2011, 2013; Schwartz
et al., 2012; Szakal and Branzei, 2013). Importantly, the late cell-
cycle activation of Mus81-Mms4 limits inappropriate actions of
this nuclease on replication forks in S phase, as premature
Cdk/Cdc5 activation has been shown to promote aberrant repli-
cation and elevated levels of crossover formation (Matos et al.,
2013; Szakal and Branzei, 2013).
In human cells, the functions of MUS81 are more diverse and
include replication fork restart (Fugger et al., 2013; Hanada
et al., 2007), common fragile site (CFS) expression (Naim et al.,
2013; Ying et al., 2013), the resolution of recombination interme-
diates (Castor et al., 2013; Chen et al., 2001; Wyatt et al., 2013),
and telomere maintenance in telomerase-negative cells (Zeng
et al., 2009). In this work, we explored the cellular role of the
little-studied MUS81-EME2 protein because, until now, it has
been assumed that all cellular functions of MUS81 are a conse-
quenceof the actions ofMUS81-EME1.Biochemical studies indi-
cate that MUS81-EME1 and MUS81-EME2 exhibit related
biochemical properties, with both nucleases exhibiting a prefer-
ence for 30-flap/fork DNA structures (Pepe and West, 2014). We
therefore set out to determine whether the cellular functions of
MUS81aredependentuponEME1orEME2,whether the twopro-
teinsmight act at different stages of the cell cycle, and the conse-
quences of loss of MUS81-EME1 or MUS81-EME2 functionality.
RESULTS
Cell-Cycle-Dependent Association ofMUS81with EME2
First, we determined whether the association of MUS81 with
EME1 or EME2 was cell-cycle dependent. GFP-FLAG-tagged
MUS81 (Wyatt et al., 2013) was expressed at endogenous levels
from is own promoter in synchronized HeLa cells carrying a bac-
terial artificial chromosome (BAC-MUS81FLAP; Figure 1A). Cell-
stage synchronization was achieved using a double thymidine
Figure 1. S Phase MUS81-EME2 Is Not
Required for SCE Formation
(A) Schematic representation of BAC-MUS81FLAP.
(B) HeLa Kyoto cells expressing MUS81FLAP were
synchronized at G1/S using a double thymidine
block. Six hours after release, the cycling cells
were supplemented with nocodazole to promote
G2/M phase arrest. Samples were collected at 0,
3, 6, 9, and 12 hr as indicated, and cell-free
extracts were prepared. MUS81FLAP was immu-
noprecipitated from the extracts and the presence
of each indicated protein was determined by
western blotting.
(C) Cell-cycle progression of the cells used in (B)
as determined by FACS analysis.
(D) Representative images of metaphase spreads
prepared from BLM-deficient cells (GM08505)
transfected with siRNAs against Luciferase
(siControl), EME2, EME1, or MUS81. Scale bar,
10 mm.
(E) Quantification of SCE formation in cells treated
with the indicated siRNAs, as shown in (D). For
each condition, 32 metaphases were analyzed
and each data point represents the number of
SCEs per 100 chromosomes per metaphase
spread; p values were determined using the two-
tailed unpaired t test with Welch correction.block, release into fresh media, and subsequent addition of
nocodazole (Figure 1B). Analysis of cellular DNA content by fluo-
rescence-activated cell sorting (FACS) showed that the majority
of the cells were efficiently synchronized at G1/S by the thymi-
dine block and proceeded through the cell cycle until prometa-
phase (Figure 1C). Samples were taken at 3 hr intervals, and
MUS81FLAP was immunoprecipitated using anti-GFP beads
and analyzed for its association with either EME1 or EME2.
MUS81 associated with EME1 throughout the cell cycle (Fig-
ure 1B, lanes a–e) and, as reported previously (Wyatt et al.,
2013), showed enhanced interaction with a second structure-
selective endonuclease, SLX1-SLX4, at prometaphase (lanes
d and e). This CDK/PLK1-driven M phase interaction ofCell Reports 7, 1048–105MUS81-EME1 with SLX1-SLX4 is neces-
sary for formation of the SLX-MUS
complex, which is required for Holliday
junction resolution (Wyatt et al., 2013).
Surprisingly, the association of MUS81
with EME2 was also cell-cycle-stage
dependent, except that EME2 was spe-
cifically pulled down by MUS81 in S
phase (Figure 1B, lanes b and c). EME2
was also detected in the MUS81 pull-
down from cells arrested in G1/S (lane
a), indicating that the MUS81-EME2
heterodimer begins to form prior to the
initiation of DNA replication.
MUS81-EME2 Is Not Required for
Holliday Junction Processing
The lack of association of MUS81 with
EME2 late in the cell cycle indicatesthat MUS81-EME2, in contrast to MUS81-EME1, is unlikely
to be involved in the resolution of recombination inter-
mediates. To determine if this was the case, we analyzed
the effect of small interfering RNA (siRNA)-mediated depletion
of MUS81, EME1, or EME2 on the frequency of sister chro-
matid exchanges (SCEs) in cell lines derived from an individ-
ual with Bloom’s syndrome (the high SCE frequency in these
cells is due to elevated crossover formation arising from
MUS81-mediated Holliday junction resolution) (Wechsler
et al., 2011; Wyatt et al., 2013). Depletion of MUS81 or
EME1, but not EME2, led to a significant reduction in the
number of SCEs (Figures 1D and 1E). These results show
that Holliday junction resolution, which occurs late in the5, May 22, 2014 ª2014 The Authors 1049
Figure 2. MUS81-EME2 Promotes the Breakage and Restart of Stalled Replication Forks
(A) HeLa cells depleted for MUS81, EME1, or EME2were treated with the indicated concentrations of HU for 24 hr and the DNAwas analyzed for breaks by PFGE.
(B) Quantification of HU-induced DSB formation, as determined in (A), expressed as the ratio of broken to intact DNA. Data are presented as a mean of three
experiments (± SEM).
(C) HeLa cells transfected with the indicated siRNAs for 48 hr before addition of HU (2 mM for 24 hr) were analyzed by fiber analyses for replication fork pro-
gression. Representative images of iododeoxyuridine (IdU)-labeled (green) and chlorodeoxyuridine (CldU)-labeled (red) DNA fibers are shown.
(D) Quantification of the fiber analyses indicated in (C) ± SEM. Statistical significance was calculated using Fisher’s exact test; 300 fibers were scored for each
condition.
See also Figure S1.cell cycle, is dependent upon MUS81-EME1 but does not
require MUS81-EME2.
MUS81-EME2 Promotes Replication Fork Restart
and Genome Stability
Previously, it was shown that MUS81 is required for DSB forma-
tion at stalled replication forks (Fugger et al., 2013; Hanada et al.,
2007). The contribution of EME1 and EME2 to fork restart, how-
ever, has not been investigated and it has been assumedwithout
supporting evidence that MUS81-EME1 promotes this critical
cellular function. Using hydroxyurea (HU), which depletes the
cellular pool of deoxynucleotide triphosphates (dNTPs) and
causes replication fork stalling and subsequent MUS81-depen-
dent DSB formation, we determined whether DSB formation
was dependent on MUS81-EME1 or MUS81-EME2. Forty-eight
hours after transfection of HeLa cells with siRNAs against
MUS81, EME1, or EME2, the cells were treated with increasing
concentrations of HU, and DSB formation was analyzed by
pulsed-field gel electrophoresis (PFGE). Consistent with previ-1050 Cell Reports 7, 1048–1055, May 22, 2014 ª2014 The Authorsous observations (Fugger et al., 2013; Hanada et al., 2007),
depletion of MUS81 resulted in a significant decrease in DSB
formation following treatment with HU (Figures 2A and 2B).
However, DSB formation in EME1-depleted cells was com-
parable to that in control siRNA-transfected cells, whereas
depletion of EME2 caused a decrease in DSB formation compa-
rable to that obtained in MUS81-depleted cells. Similar results
were obtained using a second, nonoverlapping EME2 siRNA
(siEME2 #2; Figure S1A), or when replication forks were stalled
using the interstrand crosslinking agent cisplatin (Figures S1B–
S1D). Thus, MUS81-EME2, rather than MUS81-EME1, is
required for the collapse of stalled RFs after prolonged treatment
with either HU or cisplatin.
Next, we compared the ability of MUS81-, EME1-, or EME2-
depleted cells to restart stalled replication forks using DNA
combing techniques. Remarkably, we found that depletion of
MUS81 or EME2, but not EME1, blocked replication fork restart
after HU treatment (Figures 2C and 2D). Taken together, these
results indicate that MUS81-EME2, rather than MUS81-EME1,
Figure 3. MUS81-EME2 Is Required for Genome Stability
(A) Representative images of chromosomal aberrations observed in metaphase spreads prepared fromMUS81- or EME2-depleted RPE-1 hTERT cells following
HU treatment. Images were categorized as breaks, radials, dicentrics, or acentrics, and quantified as described in (B) and Table S1.
(B) Quantification of the frequency of chromosomal breaks and fragments in siRNA-depleted RPE-1 hTERT cells with or without HU (1 mM, 24 hr) treatment. Data
are presented as the mean of three experiments (± SEM). Statistical significance was calculated using Student’s t test. 50 metaphase spreads were scored for
each condition.
(C) Quantification of anaphase bridge formation in siRNA-depleted treated cells following treatment with either APH or HU (±SEM). Cells were transfectedwith the
indicated siRNAs for 48 hr before treatment with APH (150 nM for 16 hr) or HU (1 mM for 24 hr). HU-treated cells were incubated in fresh media for 24 hr before
staining. Statistical significance was calculated using Fisher’s exact test (*p < 0.05; **p < 0.01; ***p < 0.001); 300 cells were scored for each condition.
(D) Representative image of a metaphase spread of RPE1-hTERT cells transfected with control siRNA and treated with 150 nM APH for 16 hr. Scale bar, 10 mm.
The arrow indicates a typical break as quantified in (E).
(E) Quantification of breaks in metaphase spreads in the indicated siRNA-depleted cells following treatment with 150 nM APH for 16 hr (± SEM). Statistical
significance was calculated using Student’s t test; 50 metaphases were scored for each condition.is required for the processing and restart of stalled replication
forks, consistent with the S phase specificity of MUS81-EME2
complex formation.
Defects in replication fork restart lead to an accumulation of
underreplicated DNA that will affect chromosome segregation
at mitosis, resulting in increased levels of chromosomal aberra-
tions, such as breaks and fragments, and an increased level of
DAPI-positive anaphase bridges. To determine the frequency
of chromosomal aberrations after MUS81, EME1, or EME2
depletion, we prepared metaphase spreads from untransformed
RPE-1 hTERT cells that were either treated with HU for 24 hr or
left untreated. We found that untreated cells depleted for any
of the three proteins showed a mild increase in chromosomal
aberrations compared with the control (Figures 3A and 3B;
Table S1). Treatment with HU, however, further increased the
frequency of chromosome aberrations, and cells depleted for
either MUS81 or EME2 showed a 2-fold increase in the number
of aberrant chromosomes compared with control or EME1-
depleted cells (Figure 3B; Table S1).CNext, we analyzed anaphase bridge formation following
MUS81, EME1, or EME2 depletion, and found that loss of
MUS81 or EME2 resulted in an increase in the number of cells
that displayed segregation defects after HU treatment (Fig-
ure 3C). These results support the proposal that MUS81-EME2
is important for the maintenance of genome stability following
replication fork stalling.
Nucleolytic Cleavage for CFS Expression
Recent studies have shown that MUS81 (and by inference
MUS81-EME1) is important for CFS expression, a process by
which difficult to replicate regions of the chromosome are broken
in order to permit cell division (Naim et al., 2013; Ying et al.,
2013). These regions are present on all human chromosomes
and have been linkedwith neurological diseases and cancer pre-
disposition (Durkin and Glover, 2007). To determine whether
MUS81-EME1 is indeed responsible for CFS expression, which
occurs in long genes that continue replication through the G2
phase of the cell cycle, we treated cells depleted for MUS81,ell Reports 7, 1048–1055, May 22, 2014 ª2014 The Authors 1051
EME1, or EME2 with a low dose of aphidicolin (APH), which
induces mild replication stress, and monitored the number of
metaphase breaks. We found that metaphase spreads from
MUS81- or EME1-depleted cells, but not those depleted for
EME2, exhibited a significant reduction in the frequency of chro-
mosomal breaks when compared with control cells (Figures 3D
and 3E). We also determined the frequency of anaphase bridge
formation in the APH-treated cells and observed that segrega-
tion defects were observed in the MUS81- and EME1-depleted
cells, but not in those lacking EME2. These results indicate
that MUS81-EME1, rather than MUS81-EME2, is required for
CFS expression, consistent with the notion that late replication
intermediates are processed at a cell-cycle stage during which
the MUS81-EME2 complex fails to exist.
MUS81-EME2 Promotes Telomere Maintenance
in ALT Cells
Finally, we determined whether MUS81-EME1 or MUS81-EME2
promotes telomere maintenance in telomerase-negative ALT
(Alternative Lengthening of Telomeres) cells. Previously, it was
shown that MUS81 localizes to APBs and that its depletion re-
sults in increased telomere loss and reduced telomere recombi-
nation (Zeng et al., 2009; Zeng and Yang, 2009). Since both
EME1 and EME2 localize to APBs in ALT cells (data not shown),
we determined the levels of telomere loss by quantitative fluores-
cent in situ hybridization (Q-FISH) analysis, and the frequency of
telomere recombination by chromosome orientation FISH (CO-
FISH), after depletion of MUS81, EME1, or EME2. Using ALT-
positive U2OS cells, we found that depletion of MUS81, and to
a greater extent EME2, resulted in an increased frequency of
telomere-free chromosome ends as measured by Q-FISH (Fig-
ures 4A, 4B, and S2A). In contrast, the number of telomere-
free ends in the EME1-depleted cells was comparable to the
control depletion. Increased numbers of telomere-free ends
were also observed in codepletions of MUS81 + EME2 or
EME1 + EME2 (Figure 4B). However, when we measured telo-
mere length by flow-FISH, we did not observe a significant
difference between the control and MUS81-, EME1-, or EME2-
depleted cells, indicating that loss of MUS81-EME2 functionality
promotes telomere loss rather than gradual telomere shortening
(Figure S2B). In contrast to the results observed with ALT-posi-
tive cells, which showed a significant increase in the number of
telomere-free ends, Q-FISH analysis on metaphase spreads
from telomerase-positive HT1080 cells transfected with control,
MUS81, EME1, or EME2 siRNAs revealed no significant differ-
ences (Figure S3). Consistent with this difference between telo-
merase-positive and -negative cells, EME2 depletion caused a
delay in the cell-cycle progression of ALT, but not telomerase-
positive, cells (Figure S4).
We also investigated whether the loss of EME2 function
affected the rate of telomeric SCEs (T-SCEs), a measure of telo-
meric recombination, in ALT cells. We found that depletion of
MUS81 or EME2 from U2OS cells led to a significant decrease
in the frequency of T-SCEs compared with control-transfected
or EME1-depleted cells as measured by CO-FISH (Figures 4C
and 4D). Taken together, these results define a role for
MUS81-EME2, but not MUS81-EME1, in telomere maintenance
in ALT-positive cells.1052 Cell Reports 7, 1048–1055, May 22, 2014 ª2014 The AuthorsDISCUSSION
Thework presented here shows thatMUS81-EME1 andMUS81-
EME2 promote distinct cellular functions, and that their actions
are dependent on the cell-cycle stage. We find that MUS81-
EME2 directs the S phase-specific processing of stalled replica-
tion forks to promote fork restart, and that its function is required
for telomere maintenance in ALT cells. Depletion of MUS81 or
EME2 led to an increased frequency of telomere-free ends in
U2OS cells, whereas overall telomere length remained un-
changed. These results indicate that a defect in MUS81-EME2
does not lead to gradual telomere loss; rather, the problem lies
in telomere replication. Depletion of proteins involved in the
repair of stalled replication forks, such as WRN, FEN1, FANCD2,
and MUS81, leads to an elevated rate of telomere loss that is
specifically observed in ALT cells (Crabbe et al., 2004; Fan
et al., 2009; Saharia et al., 2010; Zeng and Yang, 2009). It is
therefore possible that ALT cells are sensitive to defects in the
repair of stalled forks and, because telomere replication is unidi-
rectional and starts from the subtelomeric region, that the unre-
paired forks would cause the loss of distal telomeric sequences.
Conversely, CFS expression and the resolution of recombina-
tion intermediates, two events that occur at prometaphase,
require MUS81-EME1, but not MUS81-EME2. Most likely,
this reflects the cell-cycle-stage-dependent activities of the
two MUS81 complexes. Indeed, whereas EME1 interacts with
MUS81 throughout the cell cycle, the interaction between
MUS81 and EME2 occurs predominantly during S phase. How
the formation of the MUS81-EME2 complex is prevented during
G2 and M phase is presently unknown and will be the subject of
future study. Interestingly, although the MUS81-EME1 complex
exists throughout the cell cycle, the interaction with SLX1-
SLX4, which is required for Holliday junction resolution and chro-
mosome segregation, occurs predominantly during G2/M
(Castor et al., 2013; Garner et al., 2013; Wyatt et al., 2013).
Whether formation of the SLX-MUS complex is also required
for CFS expression remains to be determined.
In simple organisms such as yeast, Mus81 has Mms4 as a
single partner protein, and, in contrast to mammalian cells, there
is currently no evidence of interactions between Mus81-
Mms4 and Slx1-Slx4. The existence of two MUS81 complexes
in mammalian cells presumably reflects the higher level of
complexity that is required to coordinate and control the diverse
range of cellular events mediated by MUS81. Our work defines
distinct MUS81-EME2-specific events that occur in S phase, in
contrast to MUS81-EME1’s G2/M-specific functions, which
occur following SLX1-SLX4 interaction or activation (Wyatt
et al., 2013). This distinction holds promise for the development
of pharmaceutical agents that can specifically target replication-
specific functions of this critical protein.
EXPERIMENTAL PROCEDURES
All experimental procedures are described in detail in Supplemental Experi-
mental Procedures.
Cell Lines and Analyses
The following cell lines were cultured in Dulbecco’s modified Eagle’s medium
supplemented with 10% (v/v) fetal bovine serum: telomerase-positive HeLa
Figure 4. MUS81-EME2 Is Required for Telomere Maintenance in ALT Cells
(A) Representative Q-FISH images of metaphase spreads from U2OS cells depleted for the indicated proteins. Telomeric repeats are indicated in red. The arrows
point to a normal chromosome (A) or to chromosomes with telomere-free ends (B and C).
(B) Quantification of telomere-free chromosome ends in the depleted cells (± SEM), as in (A).
(C) Representative CO-FISH images of metaphase spreads from U2OS cells depleted for the indicated proteins. T-SCEs were detected using telomeric G-strand
(red) and C-strand (green) PNA probes. Arrows point to chromosomes without T-SCEs (A) and to chromosomes with telomeric exchange signals (yellow, B
and C).
(D) Quantification of chromosome ends displaying T-SCEs in the depleted U2OS cells (± SEM), as in (C).
In (B) and (D), statistical significance was calculated using Pearson’s chi-square test; n indicates the number of chromosome ends analyzed. See also Figures
S2–S4.Kyoto and HT1080, ALT-positive U2OS and GM847, the SV40-transformed
Bloom’s syndrome skin fibroblast line GM08505, and the TERT-immortalized
retinal pigment epithelial cell line RPE1-hTERT. All cultures were grown at
37C in a 10% CO2 humidified incubator.
Proteins were depleted using siRNAs. One day before transfection, the cells
were seeded in culture plates and transfected with EME1 (40 nM), EME2
(80 nM), EME2 #2 (80 nM), or MUS81 (60 nM) siRNAs using Lipofectamine
RNAiMAX. Cells were transfected with MUS81 siRNA two times within 24 hr,
whereas all other transfections were performed once, and cells were collected
72 hr after the first transfection. The control siRNA was Luciferase GL2.CThe efficiency of protein depletion was monitored by western blotting
(Figures S2C and S2D). Depletion of MUS81 led to a reduction in the levels
of MUS81, EME1, and EME2, indicating that the stability of EME1 and EME2
is dependent on interaction with MUS81. Depletion of EME1 also partially
depleted MUS81. Depletion of EME2 had no effect on the levels of either
MUS81 or EME1.
PFGE and DNA combing were performed essentially as described previ-
ously (Hanada et al., 2007; Michalet et al., 1997). SCE analyses were carried
out essentially as described previously (Bayani and Squire, 2005). Telomere
loss was analyzed by Q-FISH (Blasco et al., 1997; Zijlmans et al., 1997) andell Reports 7, 1048–1055, May 22, 2014 ª2014 The Authors 1053
the frequency of telomere recombination was determined by CO-FISH after
depletion of MUS81, EME1, or EME2 as described in Supplemental Experi-
mental Procedures.
Immunoprecipitation
HeLa Kyoto cells expressing endogenous levels of MUS81FLAP (Matos
et al., 2011) were synchronized by treatment with thymidine (2.5 mM thymi-
dine) and nocodazole (100 ng/ml). MUS81 was immunoprecipitated from ex-
tracts using the GFP-tag and the pull-downs were analyzed by western
blotting.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2014.04.007.
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